Research Articles
A Clinical Trial Revolution: How Targeted Therapy is Changing CLL Treatment for Younger Patients
Explore the groundbreaking ECOG-ACRIN E1912 trial comparing targeted therapy versus chemotherapy for chronic lymphocytic leukemia treatment in younger patients.
Breaking New Ground in Cancer Therapy: The CIGB-M3 Antibody Fragment
Explore the groundbreaking Phase I clinical trial of (131)I-labeled CIGB-M3 antibody fragment for targeted colorectal cancer treatment using radioimmunotheranostics.
The I-SPY 2 Trial: Revolutionizing Breast Cancer Treatment Through Adaptive Design
Explore how the groundbreaking I-SPY 2 trial is transforming breast cancer treatment through adaptive clinical trial design and personalized medicine approaches.
Daratumumab and Pembrolizumab: A Dual Attack on Refractory Multiple Myeloma
Exploring the promising combination of daratumumab and pembrolizumab as immunotherapy for refractory multiple myeloma in a phase 2 clinical trial.
Training the Immune System to Fight Cancer: A Tale of Two Antibodies
Exploring the RANIDO clinical trial and how immunotherapy with Racotumomab and Nimotuzumab is revolutionizing head and neck cancer treatment.
LCL161: A New Hope for Myelofibrosis Patients When Conventional Treatments Fail
Exploring the promising results of phase 2 clinical trial of LCL161, a novel SMAC mimetic for intermediate to high-risk myelofibrosis patients.
A Common Diabetes Drug for a Rare Blood Condition: Can Metformin Stop Cancer Before It Starts?
Exploring a groundbreaking clinical trial testing metformin for preventing progression from MGUS and smoldering multiple myeloma to active cancer.